The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Radulovic, Katarina ^a   Rossini, Valerio ^a   Manta, Calin ^a   Holzmann, Karlheinz ^a   Kestler, Hans A ^a   Niess, Jan Hendrik ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CD69 ANTIGEN; CHEMOKINE RECEPTOR; DEXTRAN SULFATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL 1 GENE; CCL 10 GENE; CCL 19 GENE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; LAMINA PROPRIA; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL1; CHEMOKINE CCL19; CHEMOKINE CXCL10; CHEMOKINES; COLITIS, ULCERATIVE; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTESTINES; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

MURINAE; MUS;

EID: 84878920140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065413     Document Type: Article

References (50)

1. Elgueta R, Sepulveda FE, Vilches F, Vargas L, Mora JR, et al. (2008) Imprinting of CCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells. J Immunol 180: 6501-6507.
2. Hammerschmidt SI, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, et al. (2011) Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 121: 3051-3061.
3. Mora JR, (2008) Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. Inflamm Bowel Dis 14: 275-289.
4. Grigorova IL, Schwab SR, Phan TG, Pham TH, Okada T, et al. (2009) Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat Immunol 10: 58-65.
5. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360.
6. Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, et al. (2001) Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm Bowel Dis 7: 281-286.
7. Wang C, Kang SG, Lee J, Sun Z, Kim CH, (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2: 173-183.
8. Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, et al. (2006) CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 177: 6940-6951.
9. Mackay CR, (2008) Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol 9: 988-998.
10. Deguchi Y, Andoh A, Yagi Y, Bamba S, Inatomi O, et al. (2006) The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol Rep 16: 699-703.
11. Mizushima T, Ito T, Kishi D, Kai Y, Tamagawa H, et al. (2004) Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm Bowel Dis 10: 182-192.
12. Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, et al. (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362: 387-401.
13. Sanna MG, Liao J, Jo E, Alfonso C, Ahn MY, et al. (2004) Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 279: 13839-13848.
14. Sanada Y, Mizushima T, Kai Y, Nishimura J, Hagiya H, et al. (2011) Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis. PLoS One 6: e23933.
15. Song J, Matsuda C, Kai Y, Nishida T, Nakajima K, et al. (2008) A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J Pharmacol Exp Ther 324: 276-283.
16. Martin P, Gomez M, Lamana A, Matesanz Marin A, Cortes JR, et al. (2010) The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J Allergy Clin Immunol 126: 355-365, 365 e351-353.
17. Miki-Hosokawa T, Hasegawa A, Iwamura C, Shinoda K, Tofukuji S, et al. (2009) CD69 controls the pathogenesis of allergic airway inflammation. J Immunol 183: 8203-8215.
18. Murata K, Inami M, Hasegawa A, Kubo S, Kimura M, et al. (2003) CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol 15: 987-992.
19. Sancho D, Gomez M, Viedma F, Esplugues E, Gordon-Alonso M, et al. (2003) CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest 112: 872-882.
20. Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, et al. (2012) CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J Immunol 188: 2001-2013.
21. Cruz-Adalia A, Jimenez-Borreguero LJ, Ramirez-Huesca M, Chico-Calero I, Barreiro O, et al. (2010) CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation 122: 1396-1404.
22. Vega-Ramos J, Alari-Pahissa E, Valle JD, Carrasco-Marin E, Esplugues E, et al. (2010) CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection. Immunol Cell Biol 88: 707-715.
23. Esplugues E, Vega-Ramos J, Cartoixa D, Vazquez BN, Salaet I, et al. (2005) Induction of tumor NK-cell immunity by anti-CD69 antibody therapy. Blood 105: 4399-4406.
24. Esplugues E, Sancho D, Vega-Ramos J, Martinez C, Syrbe U, et al. (2003) Enhanced antitumor immunity in mice deficient in CD69. J Exp Med 197: 1093-1106.
25. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA, (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99-146.
26. Martin P, Gomez M, Lamana A, Cruz-Adalia A, Ramirez-Huesca M, et al. (2010) CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol Cell Biol 30: 4877-4889.
27. Han Y, Guo Q, Zhang M, Chen Z, Cao X, (2009) CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 182: 111-120.
28. Lu SY, Huang XJ, Liu KY, Liu DH, Xu LP, (2012) High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants. Clin Transplant 26: E158-167.
29. Zhao Q, Kuang DM, Wu Y, Xiao X, Li XF, et al. (2012) Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol 188: 1117-1124.
30. Feng C, Woodside KJ, Vance BA, El-Khoury D, Canelles M, et al. (2002) A potential role for CD69 in thymocyte emigration. Int Immunol 14: 535-544.
31. Nakayama T, Kasprowicz DJ, Yamashita M, Schubert LA, Gillard G, et al. (2002) The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J Immunol 168: 87-94.
32. Grigorova IL, Panteleev M, Cyster JG, (2010) Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure. Proc Natl Acad Sci U S A 107: 20447-20452.
33. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, et al. (2006) CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
34. Lamana A, Martin P, de la Fuente H, Martinez-Munoz L, Cruz-Adalia A, et al. (2011) CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. J Invest Dermatol 131: 1503-1512.
35. Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, et al. (2004) Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40: 241-246.
36. Roman E, Shino H, Qin FX, Liu YJ, (2010) Cutting edge: Hematopoietic-derived APCs select regulatory T cells in thymus. J Immunol 185: 3819-3823.
37. Niess JH, Leithauser F, Adler G, Reimann J, (2008) Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol 180: 559-568.
38. Niess JH, Adler G, (2010) Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. J Immunol 184: 2026-2037.
39. De Calisto J, Villablanca EJ, Wang S, Bono MR, Rosemblatt M, et al. (2012) T-cell homing to the gut mucosa: general concepts and methodological considerations. Methods Mol Biol 757: 411-434.
40. Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH, (1993) Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem 41: 1679-1687.
41. Casazza JP, Brenchley JM, Hill BJ, Ayana R, Ambrozak D, et al. (2009) Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection. PLoS Pathog 5: e1000646.
42. McLoughlin RM, Solinga RM, Rich J, Zaleski KJ, Cocchiaro JL, et al. (2006) CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A 103: 10408-10413.
43. Wurbel MA, McIntire MG, Dwyer P, Fiebiger E, (2011) CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One 6: e16442.
44. Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, et al. (2011) Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology 141: 2109-2118.
45. Nicholson MW, Barclay AN, Singer MS, Rosen SD, van der Merwe PA, (1998) Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1. J Biol Chem 273: 763-770.
46. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC, (1993) L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366: 695-698.
47. Cauley LS, Cookenham T, Miller TB, Adams PS, Vignali KM, et al. (2002) Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J Immunol 169: 6655-6658.
48. Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L, et al. (2011) Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187: 5510-5514.
49. Cauley LS, Lefrancois L, (2013) Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 6: 14-23.
50. Bromley SK, Yan S, Tomura M, Kanagawa O, Luster AD, (2013) Recirculating memory T cells are a unique subset of CD4+ T cells with a distinct phenotype and migratory pattern. J Immunol 190: 970-976.